Related Experiment Video

Updated: Jul 7, 2026

The Soft Agar Colony Formation Assay
08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

Sulindac suppresses beta-catenin expression in human cancer cells

Anjia Han1, Zibo Song, Chang Tong

  • 1Department of Pathology, University of Illinois at Chicago, Chicago, IL 60612, USA.

European Journal of Pharmacology
|February 23, 2008
PubMed

Insights

Sulindac inhibits cancer cell proliferation by suppressing the beta-catenin pathway, impacting key genes like c-myc and cyclin D1. This effect was observed across breast, lung, and colon cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Sulindac is known to suppress tumor growth via p21WAF1/cip1 induction in colon cancer.
  • The efficacy of sulindac in other cancer types and its underlying mechanisms require further investigation.

Purpose of the Study:

  • To investigate the effects of sulindac on breast, lung, and colon cancer cell lines.
  • To elucidate the molecular mechanisms by which sulindac inhibits cancer cell proliferation.

Main Methods:

  • Treatment of human breast (MCF-7), lung (A549), and colon (SW620) cancer cell lines with sulindac.
  • Assessment of cell proliferation and apoptosis.
  • Western blot analysis to evaluate p21 and beta-catenin protein levels.
  • Analysis of beta-catenin transcriptional activity and its downstream targets (c-myc, cyclin D1, cdk 4).

Main Results:

  • Sulindac significantly inhibited proliferation in all three cancer cell lines.
  • Apoptosis was induced in lung and colon cancer cells, but not breast cancer cells.
  • Sulindac suppressed beta-catenin signaling pathway activity in a dose-dependent manner across all cell lines.
  • Downregulation of beta-catenin transcriptional targets, including c-myc, cyclin D1, and cdk 4, was observed.

Conclusions:

  • Sulindac's efficacy in inhibiting cancer cell proliferation is primarily mediated through the suppression of the beta-catenin signaling pathway.
  • The induction of apoptosis by sulindac varies by cancer cell type.
  • Targeting the beta-catenin pathway represents a potential therapeutic strategy for various human cancers.

Related Concept Videos

Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...